Daniel Karlsberg, MD, FACC, FSCCT
Dr. Karlsberg is board certified by the American Board of Internal Medicine (ABIM) in both internal medicine and cardiovascular disease. Additionally, he holds board certifications in comprehensive echocardiography, nuclear cardiology, and level III cardiovascular CT. He is currently on the clinical faculty at NYU Langone Health in the Department of Medicine & Division of Cardiology. […]
Graham Pawelec, PhD
Graham Pawelec is an advisor to Repair Biotechnologies, with deep expertise in immunology and oncology. He is currently Professor of Experimental Immunology in the Department of Immunology, University of Tübingen, Tübingen, Germany and is a member of the Cancer Solutions Program at the Health Sciences North Research Institute of Canada, Sudbury, ON, Canada. Dr. Pawelec […]
Ronald Karlsberg, MD, FACC, MSCCT, FAHA, FACP
Dr. Karlsberg is a Clinical Professor of Medicine at the David Geffen School of Medicine UCLA specializing in clinical and interventional cardiology. He is a fellow of the American College of Cardiology, the American Heart Association, the Society of Cardiovascular Computed Tomography, and the American College of Physicians. Dr. Karlsberg has a special interest in […]
Richard Honkanen, PhD
Richard Honkanen is the inventor of the original technology on which Repair Biotechnologies’ CDP platform is based. He is a Professor in the Department of Biochemistry & Molecular Biology in the College of Medicine, University of South Alabama. Dr. Honkanen’s lab has been a pioneer in the study of atherosclerosis and other age-related diseases, having […]
Bobby Khan, MD, PhD
Bobby Khan is the Chief Medical Officer of Repair Biotechnologies. He is a cardiologist and clinical investigator, serving as Professor of Medicine at the University of Central Florida School of Medicine. Dr. Khan has published nearly 90 peer-reviewed articles in the areas of cardiovascular and metabolic disorders in highly regarded scientific journals. He is co-founder […]
Mourad Topors, PhD
Mourad is the Chief Scientific Officer at Repair Biotechnologies. He has over 20 years of experience in successfully leading multidisciplinary teams in translational medical research, focusing on cardiovascular disease. Formerly, he was a Faculty member and Principal Investigator at Harvard Medical School as well as the project architect and team leader of a drug development […]
Reason
Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeutics. He is a long-standing and well-connected patient advocate for aging research, involved in numerous fundraising and outreach initiatives conducted by organizations such as the […]
